| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |